Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (20)
Modulation of the alternative complement pathways by beta 1 H globulin.
1976 • 586 citations
Control of the amplification convertase of complement by the plasma protein beta1H.
1976 • 571 citations
Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
1975 • 267 citations
The Demonstration in Human Serum of “Conglutinogen-Activating Factor” and its Effect on the Third Component of Complement
1968 • 206 citations
Metabolic Studies of the Third Component of Complement and the Glycine-Rich Beta Glycoprotein in Patients with Hypocomplementemia
1974 • 156 citations
The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).
1973 • 153 citations
C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
1969 • 144 citations
Variable patterns of immunoglobulin and complement deposition in the kidneys of patients with systemic lupus erythematosus.
1969 • 136 citations
Metabolism of Third Complement Component (C3) in Nephritis
1972 • 130 citations
Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia
1971 • 127 citations
CHARACTERISTICS OF A NON-COMPLEMENT-DEPENDENT C3-REACTIVE COMPLEX FORMED FROM FACTORS IN NEPHRITIC AND NORMAL SERUM
1970 • 97 citations
Properdin and C3 Proactivator: Alternate Pathway Components in Human Glomerulonephritis
1973 • 95 citations
A second case of human C3b inhibitor (KAF) deficiency.
1977 • 85 citations
Studies of serum complement in the hypocomplementaemic nephritides.
1974 • 78 citations
Glomerular Complement Components in Human Glomerulonephritis
1974 • 72 citations
Decreased Properdin Activity in Acute Glomerulonephritis
1969 • 51 citations
Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum.
1978 • 33 citations
C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
1976 • 31 citations
Metabolism of properdin in normal subjects and patients with renal disease.
1975 • 27 citations
Correlations between serum factor B and C3b inactivator levels in normal subjects and in patients with infections, nephrosis and hypocomplementaemic glomerulonephritis.
1977 • 22 citations
Cited By (0)
No citing papers found in database